w7 Flashcards

1
Q

Cochleotoxic

A

: results in cochlear damage and CN VIII; auditory dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Vestibulotoxic

A

results in damage to vestibular end organs & CNVIII; vestibular dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ototoxic Symptoms

A

Tinnitus (typically)- constant, high pitch
SNHL (typically)- High freq with progression to mid/low freq (most agents); mid frequency (loop diuretics); difficulties understanding speech in noise
Vestibular dysfunction: disequilibrium, imbalance, vertigo & nystagmus
- may go unnoticed by patients until a communication problem becomes apparent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 main classes responsible for permanent otoxic damage:

A
  1. aminoglycoside antibiotics
  2. antineoplastic (chemotherapeutic)- may be reversable initially
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

aminoglycoside antibiotics

A

resistant bacterial infections, induced vestibulotoxcity for relief of vestibulopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

antineoplastic medications

A

tumor treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diuretics

A

management of excess body fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drug administration

A

Systemic application (bilateral effects): affecting whole body (i.e., intramuscular, intravenous, oral
Topical (unilateral affects): skin or mucous membrane application, apply drug to specific target
Cochlea (unilateral effects) Round window: drug applied to surface of round window
Direct perfusion: invasive procedure by injecting drug directly into perilymph or endolymph

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Salicylates

A

pain, anti-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ototoxic incidence

A

Incidence varies depends on definition of ototoxity, classification of medication & drug type (loop 1-6% and antineoplastic drug cisplatinum 25-90% , dosage schedule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • ototoxic drugs can induce stress signals which initiate cell death occurring via 2 mechanisms (which interact)
A

necrosis and apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

apoptosis HC death

A

apoptosis: active, programmed cell death, controlled process by which cells self-destruct
- no inflammation of neighbouring tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

necrotic HC death

A

Necrosis: passive form of cell death, unregulated release of cellular debris into the intracellular space
- neighbouring phagocytes find difficulty in locating and eliminating cell by-products (immune response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

oxidative stress

A

when free radicals are floating around causing stress on cell until they find electron they are looking for; free radicals start to steal electrons from other cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

stress signalling in auditory haircell death

A
  1. Oxidative stress: occurs early in the damage process
    - Accumulation of intracellular free radicals in the form of reactive oxygen species (ROS) and reactive nitrogen species (RNS)
    - Oxidative stress results from an imbalance between ROS and antioxidants
    - Excess ROS and RNS cause damage by reacting with DNA, proteins, cytosolic molecules, cell surface receptors, and breaking down membrane lipids
  2. Expression of extracellular pro-inflammatory cytokines & other cell death signals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

aminoglycosides

A

Damage is progressive affecting serval different cochlear structures with OHC most sensitive (then IHC then spiral ganglion, stria vascularis & support cells), base more sensitive than apex (progress from high to low frequencies)
- May be cochleotoxic or vetsibulotoxic or both
- Permanent SNHL
- Individual susceptibility may be inherited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

cispaltin

A

used for cancer
- Highest ototoxic potential
- Earliest symptoms: tinnitus and high freq hearing loss
- Irreversible bilateral SNHL progress from high to low freq.
- OHC and stria vascularis most susceptible to damage
- Base more sensitive than apex
- Severe degeneration: support cells, collapse of Reisner’s membrane, eventual destruction of entire organ of corti replaced by epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

side effects of cisplatin

A

ototoxicity, nephrotoxicity, neuropathies, nausea, vomiting

19
Q

carboplatin

A

similar to cisplatin but incidence of SNHL lower, mixed OHC and IHC damage

20
Q

carboplatin chinchilla model

A

IHC most susceptible with sig. loss, ohc damage occurs with later progression (ONLY Found in chinchilla)

21
Q

loop diuretics

A

treat fluid volume overload
Ototoxicity low incidence of HL compared to aminoglycosides and antineoplastics
- Tinnitus, usually reversable SNHL, risk of permanent loss with cumulative dose
- Known to exacerbate aminoglycoside and cisplatin ototoxicity
Anatomical changes: stria vascularis: edema, damage/swelling of hair cells

22
Q

criteria for sig changes

A
  • > 20dB pue tone threshold at 1 freq
  • > 10dB shift at 2 consecutive test frequencies
  • > 5 db shift at 3 adjacent test freq.
  • If pre-existing profound loss: threshold shift to “no response” at 3 consecutive test frequencies
  • Confirmed by re-test
23
Q

audiological outcomes of ototoxicity

A

bilateral decline in thresholds (usually), progress from high to low frequencies, behavioural and physiological responses (OAEs, ABR) deteriorate in pattern reflecting damage to cochlea

24
Q

Monitoring program baseline evaluation

A

no later than 24 hours after chemotherapeutic
No later 72 hours after aminoglycoside antibiotics

25
Ototoxicity medical examination
History; other medications, chemical and/or noise exposure Physical exam: tinnitus, hearing loss, vestibular dysfunction: nystagmus Additional assessment: audiology, vestibular, radiology if retrocochlear damage suspected
26
salicylate
(Asprin)- anti-inflammatory effects Ototoxicity usually reversable, tinnitus, high frequency or flat SNHL, no clear affects on anatomy, temporary threshold shift and OAE temporarily altered Possible pathophysiological effects: OHC motility, auditory synapse
27
acute SSNHL
- Very sudden onset of unilateral SNHL that may be accompanied by acute vertigo, aural fullness/pressure and tinnitus - Medical emergency
28
criteria for ssnhl
unliateral hl of 30dB or more in 3 adjacent frequencies - Rapid progression occurring within 72 hours of initial symptoms
29
SSNHL incidence
5-27/100 000 in us ; about 1% of all SSNHL
30
SSNHL age
40-60 year olds
31
sex differences
none Male=Female
32
etiology
unknown 90% idiopathic; identifiable causes are neoplastic, infectious (autoimmune, neurologic, ototoxicity)
33
idiopathic SSNHL
rapid onset - Not explained by other identifiable cause
34
audiologic assessment for SSNHL
Clinical features: SNHL is usually unilateral, sudden & rapid, progressive (<3days) additional symptoms: vertigo, aural fullness, tinnitus Comprehensive audiologic evaluation: behavioural and objective tests - Rule out retrocochlear involvement (immittance with acoustic reflexes, OAE, ABR)
35
why is SSNHL an emergency
better prognosis if treatment starts early, rule out stroke
36
case history SSNHL
: critical to diagnosis which is based on exclusion of other known causes Goal is to rule out: specific treatable infections (bacterial or viral), cardiovascular/stroke, labyrinthine membrane rupture (trauma or barotrauma), mass lesions (retrocochlear) autoimmune (systematic or inner ear specific), ototoxicity
37
imaging for SSNHL
to rule out cerebellopontine angle tumors, MS, vascular compromise, malformations
38
laboratory evaluations SSNHL
may be considered when specific disorder is suspected (thyroid function test, bacterial infection, autoimmune disease)
39
idiopathic SSNHL medical treatments
- Varies with underlying condition but majority of cases are peripheral auditory (vestibular) disorder classified as idiopathic (likely viral) - Systemic steroids (e.g. prednisone) to reduce ear inflammation - Intratympanic steroids - Hyperbaric oxygen therapy
40
order of treatment for idopathic SSNHL
Initial is systemic prednisode then follow up treatment with corticosteroid into ME (intratympanic delivery) - HBOT recommended as initial with steroids or as salvage treatment for SSNHL
41
prognosis trends
Delay in steroids=poorer prognosis Age: younger people more favourable recovery Mild low frequency HL recovery better than mild high frequency Severe to profound loss=poor prognosis
42
audiologic monitoring of SSNHL
Monitor patients for: effect of treatment & recovery in affected ear, SNHL in contralateral ear, development of associated diseases (autoimmune) - Aural rehab for hearing that does not improve
43
Following stabilization of hearing thresholds for SSNHL what do we do and when is stabilization
3-6 months) o Consider amplification if residual SNHL o CROS if no residual hearing o ALDs o Cochlear implant
44